Chronic kidney disease (CKD) is defined as abnormalities of kidney structure or function present for at least three months. CKD is staged from 1-5 based on glomerular filtration rate. Common causes include diabetes, hypertension, glomerulonephritis and polycystic kidney disease. Treatment focuses on slowing progression, managing complications like anemia and bone disease, and preparing for renal replacement therapy with dialysis or transplantation as kidney function declines. Dialysis modalities include hemodialysis and peritoneal dialysis (continuous ambulatory, intermittent, or continuous cycler-assisted). A kidney-friendly diet limits protein, phosphorus, potassium, sodium and may restrict fluids in later stages to slow CKD
Chronic kidney disease (CKD) means your kidneys are damaged and can't filter blood the way they should. The disease is called “chronic” because the damage to your kidneys happens slowly over a long period of time.
Chronic kidney disease (CKD) means your kidneys are damaged and can't filter blood the way they should. The disease is called “chronic” because the damage to your kidneys happens slowly over a long period of time.
It is the removal of solutes and water from body across a semipermeable membrane (dialyzer)
care during and after the dialysis is very important to prevent the entry of pathogens in to the body.
Acute kidney failure happens when your kidneys suddenly lose the ability to eliminate excess salts, fluids, and waste materials from the blood. Acute kidney failure is also called acute kidney injury or acute renal failure. It's common in people who are already in the hospital. It may develop rapidly over a few hours.
CHRONIC RENAL FAILURE (CRF) or CHRONIC KIDNEY DISEASE (CKD)
Chronic or irreversible renal failure is a progressive reduction of functioning of renal tissue such that the remaining kidney mass can no longer maintain the body’s internal environment.
Chronic kidney disease (CKD) consists of a spectrum of different pathophysiologic processes associated with abnormal kidney function, and a progressive decline in glomerular filtration rate (GFR).
Urinary diversion procedures are performed to divert urine from the bladder to a new exit site, usually through a surgically created opening (stoma) in the skin.
These procedures are primarily performed when a bladder tumor necessitates removal of the entire bladder (cystectomy).
Urinary diversion has also been used in managing pelvic malignancy, birth defects, strictures, trauma to ureters and urethra, neurogenic bladder, chronic infection causing severe ureteral and renal damage, and intractable interstitial cystitis and as a last resort in managing incontinence.
There are two categories of urinary diversion:
1. Cutaneous urinary diversion : in which urine drains through an opening created in the abdominal wall and skin.
2. Continent urinary diversion : in which a portion of the intestine is used to create a new reservoir for urine.
It is the removal of solutes and water from body across a semipermeable membrane (dialyzer)
care during and after the dialysis is very important to prevent the entry of pathogens in to the body.
Acute kidney failure happens when your kidneys suddenly lose the ability to eliminate excess salts, fluids, and waste materials from the blood. Acute kidney failure is also called acute kidney injury or acute renal failure. It's common in people who are already in the hospital. It may develop rapidly over a few hours.
CHRONIC RENAL FAILURE (CRF) or CHRONIC KIDNEY DISEASE (CKD)
Chronic or irreversible renal failure is a progressive reduction of functioning of renal tissue such that the remaining kidney mass can no longer maintain the body’s internal environment.
Chronic kidney disease (CKD) consists of a spectrum of different pathophysiologic processes associated with abnormal kidney function, and a progressive decline in glomerular filtration rate (GFR).
Urinary diversion procedures are performed to divert urine from the bladder to a new exit site, usually through a surgically created opening (stoma) in the skin.
These procedures are primarily performed when a bladder tumor necessitates removal of the entire bladder (cystectomy).
Urinary diversion has also been used in managing pelvic malignancy, birth defects, strictures, trauma to ureters and urethra, neurogenic bladder, chronic infection causing severe ureteral and renal damage, and intractable interstitial cystitis and as a last resort in managing incontinence.
There are two categories of urinary diversion:
1. Cutaneous urinary diversion : in which urine drains through an opening created in the abdominal wall and skin.
2. Continent urinary diversion : in which a portion of the intestine is used to create a new reservoir for urine.
Define Chronic Renal Failure.
Mention the main causes of Chronic Renal Failure.
Know the signs and symptoms of renal failure.
Know the treatment options of CRF
Know new definition of CKD
peritoneal dialysis, management of chronic renal failureSapana Shrestha
Peritoneal dialysis is a technique of dialysis in which solute and fluid exchange occurs between peritoneal capillary blood and dialysis solution in the peritoneal cavity via peritoneal layer with the help of peritoneal catheter.
Peritoneal Dialysis – Procedure and Recovery.pdfMeghaSingh194
The kidney failure treatment known as Peritoneal Dialysis (PD) is a type of dialysis. The lining of the peritoneal cavity (the abdominal cavity) serves as the membrane through which excess fluid and waste are expelled. Let's explore more: https://www.southlakegeneralsurgery.com/peritoneal-dialysis-procedure-and-recovery/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
For those battling kidney disease and exploring treatment options, understanding when to consider a kidney transplant is crucial. This guide aims to provide valuable insights into the circumstances under which a kidney transplant at the renowned Hiranandani Hospital may be the most appropriate course of action. By addressing the key indicators and factors involved, we hope to empower patients and their families to make informed decisions about their kidney care journey.
India Diagnostic Labs Market: Dynamics, Key Players, and Industry Projections...Kumar Satyam
According to the TechSci Research report titled “India Diagnostic Labs Market Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2019-2029,” the India Diagnostic Labs Market was valued at USD 16,471.21 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 11.55% through 2029. This significant growth can be attributed to various factors, including collaborations and partnerships among leading companies, the expansion of diagnostic chains, and increasing accessibility to diagnostic services across the country. This comprehensive report delves into the market dynamics, recent trends, drivers, competitive landscape, and benefits of the research report, providing a detailed analysis of the India Diagnostic Labs Market.
Collaborations and Partnerships
Collaborations and partnerships among leading companies play a pivotal role in driving the growth of the India Diagnostic Labs Market. These strategic alliances allow companies to merge their expertise, strengthen their market positions, and offer innovative solutions. By combining resources, companies can enhance their research and development capabilities, expand their product portfolios, and improve their distribution networks. These collaborations also facilitate the sharing of technological advancements and best practices, contributing to the overall growth of the market.
Expansion of Diagnostic Chains
The expansion of diagnostic chains is a driving force behind the growing demand for diagnostic lab services. Diagnostic chains often establish multiple laboratories and diagnostic centers in various cities and regions, including urban and rural areas. This expanded network makes diagnostic services more accessible to a larger portion of the population, addressing healthcare disparities and reaching underserved populations. The presence of diagnostic chain facilities in multiple locations within a city or region provides convenience for patients, reducing travel time and effort. A broader network of labs often leads to reduced waiting times for appointments and sample collection, ensuring that patients receive timely and efficient diagnostic services.
Rising Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is a significant driver for the demand for diagnostic lab services. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require regular monitoring and diagnostic testing for effective management. The rise in chronic diseases necessitates the use of advanced diagnostic tools and technologies, driving the growth of the diagnostic labs market. Additionally, early diagnosis and timely intervention are crucial for managing chronic diseases, further boosting the demand for diagnostic lab services.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
2. 2
Topics
• What is CKD
• Stages of CKD
• Common Causes of CKD
• Pathogenesis of CKD
• Risk factors for CKD
• Symptoms of CKD
• CKD: Complications
• Diagnostic criteria for CKD
• CKD: Treatment
• When to start Dialysis?
• Dialysis
• General Principles of Dialysis
• Dialyser
• Semipermeable Membrane
• Dialysate
• Hemodialysis
• Peritoneal Dialysis
1. Continuous Ambulatory Peritoneal Dialysis (CAPD)
2. Intermittent peritoneal dialysis
3. Continuous Cycler-Assisted Peritoneal Dialysis (CCPD)
• Benefits of peritoneal Dialysis vs Hemodialysis
• Conservative Management
1. Management of hypertension
2. Management of glycemic control
3. Management of hyperphosphatemia
4. Management of Anemia
o KDIGO Clinical Practice guidelines for Anemia in CKD
5. Management of Hyperkalemia
6. Diet in CKD
• End Of Life Care (EOL)
• Do’s & Don’ts for CKD patients
• Do's & Don’ts for Dialysis patients
3. Chronic Kidney Disease
Definition:
Structural or functional abnormalities of the kidneys for ≥3months,
as manifested by either:
1. Kidney damage, with or without decreased GFR, as defined by:
• pathologic abnormalities
• markers of kidney damage, including abnormalities in
the composition of the blood or urine or abnormalities in
imaging tests
2. GFR of less than 60 ml/minute per 1.73m2
per body surface area
(normal is 125ml/min) .
4. Stages of Chronic Kidney Disease
Stage Description GFR
(ml/min/1.73m²
Action plan
1 Kidney Damage
with Normal or
↑GFR
>90 Diagnose and treat CKD,
treat comorbid conditions,
slow progression of CKD,
reduce cardiovascular risk
2 Mild ↓ GFR 60-89 Estimate progression
3 Moderate ↓ GFR 30-59 Evaluate and treat
complications
4 Severe ↓ GFR 15-29 Prepare for kidney
transplant
5 Kidney failure <15 or Dialysis Kidney transplant if uremia
present
4
5. Common Causes of CKD
CVD and its related risk
factors
(e.g. obesity, smoking)
CVD and its related risk
factors
(e.g. obesity, smoking)
Chronic glomerulonephritis
Chronic pyelonephritis
Chronic glomerulonephritis
Chronic pyelonephritis
Renal stones &
Obstructive
uropathy
Renal stones &
Obstructive
uropathy
Acute Kidney InjuryAcute Kidney Injury
Analgesics abuseAnalgesics abuse
Diabetes Mellitus
Hypertension
Diabetes Mellitus
Hypertension
5
13. 13
When to start Dialysis?
Dialysis should be instituted whenever the glomerular filtration rate (GFR) is
<15 mL/min and there is one or more of the following:
• Symptoms or signs of uraemia.
• Inability to control hydration status or blood pressure.
• Progressive deterioration in nutritional status.
In any case, dialysis should be started before the GFR has fallen to 6
mL/min/1.73m2 , even if optimal pre-dialysis care has been provided and
there are no symptoms.
KDIGO 2012 Clinical Practice Guideline for the Evaluation
and Management of Chronic Kidney Disease
14. 14
• High-risk patients e.g. diabetics may benefit from an earlier start.
• To ensure that dialysis is started before the GFR is 6mL/min, clinics
should aim to start at 8–10 mL/min.
KDIGO 2012 Clinical Practice Guideline for the Evaluation
and Management of Chronic Kidney Disease
When to start Dialysis?
17. 17
• Device by which waste products are removed from the patient's blood.
• Two main compartments of any dialyser -
1. blood compartment
2. dialysate compartment
• They are separated by a semipermeable membrane.
Dialyser
19. 19
Dialysate
• Mixture of water and salts which is used for the process of dialysis.
• Identical in concentration to those found in normal blood.
• Contains very little potassium so that potassium will be removed from the
patient during dialysis across the semipermeable membrane.
• Contains no urea or any other waste product so that their removal during
dialysis is rapid.
• water used to make dialysate contains very little calcium.
• water softener is used to prepare the water for dialysis fluid.
20. Hemodialysis
Procedure
-A fistula or graft is created to access the
bloodstream
-Wastes, excess water, and salt are removed
from blood using a dialyzer.
-Hemodialysis required approx. 3 times per
week, each treatment lasting 3-5 hrs
-Can be performed at a medical facility or at
home with appropriate patient training. Complications
-Infection at access site
-Clotting, poor blood flow
- Hypotension
20
21. Peritoneal Dialysis
Procedure
- Dialysis solution is transported into the
abdomen through a permanent catheter
where it draws wastes and excess water
from peritoneal blood vessels. The
solution is then drained from the
abdomen.
Three Types of Peritoneal Dialysis
Continuous Ambulatory Peritoneal
Dialysis (CAPD)
Intermittent peritoneal dialysis
Continuous Cycler-Assisted Peritoneal
Dialysis (CCPD)
Complications
- Peritonitis
21
22. 22
Continuous ambulatory peritoneal
dialysis: Advantages
Equipment: system of dialysis is very simple and a patient does not have to learn to use
any complicated machinery.
Training: Two or three weeks is sufficient for anyone to master the system of connecting
and disconnecting the lines from the bags.
Home life: Because there is no machinery used, no modification of the patient's home is
needed. Also the patient need depend very little upon a partner to help in dialysis, thus less
strain upon the family.
Life style: avoids travel to and from a hospital or dialysis centre for haemodialysis and
gives more time to spend with family and friends.
Contd…
23. 23
Continuous ambulatory peritoneal
dialysis: Advantages
Food and drinks: more pleasant than the small quantity of fluid
possible for the haemodialysis patient.
Drugs: Often only calcium carbonate is needed.
Health: greater improvement in the anaemia of renal failure is seen in patients on CAPD
than in those treated by haemodialysis or intermittent peritoneal dialysis.
Diabetes: CAPD is the best treatment for diabetics who develop permanent renal failure.
Insulin is added to each bag so that the diabetes is very well controlled
24. 24
Intermittent peritoneal dialysis(IPD):
Advantages
• Gentle : waste products are removed much more slowly than by haemodialysis.
• IPD doesn’t cause a patient to feel 'washed out' the day after treatment as is caused by
haemodialysis.
• Easier to learn than that of haemodialysis.
• No need to gain the skill of inserting needles into a fistula.
• 'Alarms' are less frequent and hence a dialysis is less stressful.
• Can be used for virtually all patients except for those who previously have had a number of
abdominal operations.
• Patient is able to drink more fluid than a patient who receives chronic haemodialysis.
25. 25
Continuous cycle peritoneal dialysis:
Advantages
1. Gentle and the technique easy to learn.
2. Like CAPD and IPD, fluid and diet allowances are more generous than for the patient
receiving haemodialysis. The gap between each CCPD treatment is approximately 14
hours.
3. patient is able to treat himself at home without the help of a partner.
Contd…
26. 26
• Machine used is considerably smaller than that necessary
for IPD and requires little space.
• Little or no modification of a patient's home is required to perform
CCPD.
• Chance of peritonitis is very small.
• Machine is portable
Continuous cycle peritoneal dialysis:
Advantages
28. Hypertension Control
Goal: Lower Blood Pressure To <130/80 mmhg
Antihypertensive Agents
Glycemic Control
Pre-prandial Plasma Glucose 90-130 Mg/Dl
A1c <7.0%
Peak Postprandial Plasma Glucose <180 Mg/Dl
Self-monitoring Of Blood Glucose (SMBG)
Medical Nutrition Therapy
Restrict Dietary Protein To RDA Of 0.8 G/Kg Body Weight Per Day
Conservative Management
28
30. Treatment options for Anemia in patients with CKD
30
IV IRON THERAPIES
• Iron replacement
- Iron dextran
- Iron sucrose
- Sodium ferric gluconate
- Ferumoxytol
ESA THERAPIES
o epoetin alfa
o epoetin beta
o Darbepoetin alfa
o continuous erythropoietin receptor activator (CERA)
RED BLOOD CELL TRANSFUSION
- For severe anemia
- For acute anemia
CORRECTION OF NUTRITIONAL DEFICIENCIES
Contd…
35. Hyperkalaemia and Metabolic Acidosis :
- managed with low-potassium dietary advice, medication adjustment and sodium
bicarbonate tablets
Regular dietetic input- Supplementation with Low protein diet (Ketoanalogues)
Physiotherapy
Occupational therapy
Social work input as they become less able to care for themselves at home
35
37. 37
What is a chronic kidney disease diet?
•A chronic kidney disease diet limits protein, phosphorus, sodium, and potassium.
•Liquids may also need to be limited in later stages of chronic kidney disease.
• This diet helps slow down the rate of damage to kidneys.
• Diet may change over time as health condition changes.
•Also there may be need to make other diet changes if you have other health
problems, such as diabetes.
39. 39
• Protein intake of 0.6-0.75 grams of protein per kilogram of body weight per day
(g/kg/d) for patients in stages 1-4 of CKD.
• In stage 5, when patients are receiving dialysis, increased protein intake is suggested
(approx. 1.2 g/kg/d).
• The average healthy person consumes the amount of protein equivalent to 1.2 g/kg/d.
• On basis of current K/DOQI recommendations, CKD patients in stages 1-4 need
dietary counselling to reduce their protein intake by about half.
What are the recommendations about dietary protein
in CKD?
40. 40
Proteins With Lower Fat and Cholesterol
Original Food Substitute Food
Regular ground beef 90% lean or greater ground
beef
Whole eggs Egg whites or egg substitute
Fried fish Fresh or frozen fish
Large portions of red meat Reduce to 3 oz (size of deck of
cards)
or leaner cuts of meat
Chicken breast to replace fatty
cuts of meat
41. 41
CARBOHYDRATES
If you do not have a problem eating carbohydrates, these foods are a good source of energy. If
your provider has recommended a low-protein diet, you may replace the calories from protein
with:
•Fruits, breads, grains, and vegetables. These foods provide energy, as well as fiber, minerals,
and vitamins.
•Hard candies, sugar, honey, and jelly. If needed, you can even eat high-calorie desserts such
as pies, cakes, or cookies, as long as you limit desserts made with dairy, chocolate, nuts, or
bananas.
What foods can I include?
Contd….
42. 42
FATS
•Fats can be a good source of calories.
• Make sure to use monounsaturated and polyunsaturated fats to protect
your heart health.
•Include healthy fats, such as unsaturated fats
o1 teaspoon margarine or mayonnaise
o1 teaspoon oil (safflower, sunflower, corn, soybean, olive, peanut, canola)
o1 tablespoon oil-based salad dressing (such as Italian) or 2 tablespoons
mayonnaise-based salad dressing (such as ranch).
Contd….
43. 43
CALCIUM AND PHOSPHOROUS
The minerals calcium and phosphorous will be checked often. Even in the early stages
of CKD, phosphorous levels in the blood can get too high.
This can cause:
•Low calcium. This causes the body to pull calcium from your bones, which can make
your bones weaker and more likely to break.
•Itching.
•Some dairy foods are lower in phosphorous, including:
oTub margarine
oButter
oCream, ricotta, brie cheese
oHeavy cream
oSherbet
oNondairy whipped toppings
Contd….
44. 44
POTASSIUM
Normal blood levels of potassium help keep your heart beating steadily. However, too much potassium can
build up when the kidneys no longer function well. Dangerous heart rhythms may result, which can lead to
death.
Fruits and vegetables contain large amounts of potassium, and for that reason should be avoided to maintain
a healthy heart.
Choosing the right item from each food group can help control your potassium levels.
When eating fruits:
•Choose peaches, grapes, pears, apples, berries, pineapple, plums, tangerines, and watermelon
•Limit or avoid oranges and orange juice, nectarines, kiwis, raisins or other dried fruit, bananas, cantaloupe,
honeydew, prunes, and nectarines
When eating vegetables:
•Choose broccoli, cabbage, carrots, cauliflower, celery, cucumber, eggplant, green and wax beans, lettuce,
onion, peppers, watercress, zucchini, and yellow squash
•Limit or avoid asparagus, avocado, potatoes, tomatoes or tomato sauce, winter squash, pumpkin, avocado,
and cooked spinach
Contd….
45. 45
FLUIDS
In the early stages of kidney failure, you do not need to limit the fluid you drink. But, as your condition gets
worse, or when you are on dialysis, you will need to watch the amount of liquid you take in.
In between dialysis sessions, fluid can build up in the body. Too much fluid will lead to shortness of breath,
an emergency that needs immediate medical attention.
Your provider and dialysis nurse will let you know how much you should drink every day. Keep a count of
foods that contain a lot of water, such as soups, fruit-flavored gelatin, fruit-flavored ice pops, ice cream,
grapes, melons, lettuce, tomatoes, and celery.
Use smaller cups or glasses and turn over your cup after you have finished it.
Tips to keep from becoming thirsty include:
•Avoid salty foods
•Freeze some juice in an ice cube tray and eat it like a fruit-flavored ice pop (you must count these ice cubes
in your daily amount of fluids)
•Stay cool on hot days
Contd….
46. 46
SALT OR SODIUM
Reducing sodium in your diet helps you control high blood pressure. It also keeps you
from being thirsty, and prevents your body from holding onto extra fluid.
Look for these words on food labels:
•Low-sodium
•No salt added
•Sodium-free
•Sodium-reduced
•Unsalted
Contd….
60. Treatment of common EOL symptoms in CKD patients
SYMPTOM TREATMENT OPTIONS
Pruritus Antihistamines, skin lotion with
menthol, dexamethasone
Dyspnea Relaxation exercises, diuretics,
oxygen, morphine
Pain Opioids ±adjuvants
Dry mouth Artificial saliva, swabs, good local
care
Nausea, Vomiting Haloperidol at 50% normal dose,
compazine
Constipation Senokot, stool softners, lactulose,
enemas – avoid phosphosoda,
magnesium
Respiratory tract secretions Hyoscyamine 0.125 mg po or SL,
scopolamine patch
Source : data from Davidson and douglas
60